FoundMyFitness · 2025-04-28 · Rhonda Patrick (host), Andy Galpin
Dr. Andy Galpin: The Optimal Diet, Supplement, & Recovery Protocol for Peak Performance
85 research-tied claims examined: 5 contradicted 11 overstated 4 context 58 supported 7 unverified
5 Contradicted by research
Concentrated beetroot juice or extract begins taking effect within approximately five minutes and lasts for around three hours.
"So, you can take it—you're talking about, I don't know, five minutes to take effect. Like, it happens fast, really like caffeine. You're going to have a pretty acute effect of it, and it will last—I think you can think of it like caffeine. It will last probably 3 hours-ish." (said at 1:43:15)
The claim that concentrated beetroot juice or extract begins taking effect within approximately five minutes is contradicted by pharmacokinetic and metabolic evidence. Dietary inorganic nitrate in beetroot juice requires enterosalivary circulation: it is absorbed in the gastrointestinal tract into systemic circulation, concentrated in saliva, reduced to nitrite by oral bacteria, and swallowed to enter systemic circulation as nitrite and nitric oxide. Randomized pharmacokinetic studies show that plasma nitrate and nitrite concentrations, as well as subsequent cardiovascular effects, do not peak immediately within minutes; instead, peak plasma nitrite and blood pressure reductions typically manifest 2 to 3 hours post-ingestion, and elevated nitric oxide metabolites remain detectable for up to 24 hours.
Consuming high doses of caffeine, such as 8 to 10 mg/kg, leads to decrements in endurance performance.
"If you go too high on caffeine, you'll actually see performance decrements, like endurance performance decrements way high. Like that stuff, like I said earlier, 8 to 10 milligrams per kilogram, you'll start to see performance come down." (said at 2:04:39)
Randomized controlled trials evaluating high doses of caffeine (e.g., 9 mg/kg) show that they still enhance endurance performance rather than causing performance decrements compared to placebo. For example, a randomized crossover trial in trained endurance athletes found that 9 mg/kg of caffeine significantly prolonged time to exhaustion during running (71.0 vs. 49.2 minutes) and cycling (59.3 vs. 39.2 minutes) relative to placebo. Expert consensus from the International Society of Sports Nutrition (ISSN) indicates that while very high doses (e.g., 9 mg/kg) significantly increase the incidence of adverse effects (such as tremors, anxiety, and gastrointestinal distress) and provide no additional benefit over moderate doses (3 to 6 mg/kg), they do not cause net endurance performance decrements.
Plasma levels of vitamin C peak after ingestion and return close to baseline after approximately three hours.
"your plasma levels peak and then it goes pretty close back to baseline I want to say after like 3 hours or so." (said at 2:11:50)
Pharmacokinetic data on oral vitamin C in healthy humans indicate that peak plasma concentrations (Tmax) occur approximately 2 to 4 hours after ingestion. Because plasma levels are reaching their maximum around 3 hours post-ingestion, they do not return close to baseline within 3 hours; clearance and elimination back toward baseline take considerably longer.
The metric known as the Sleep Quality Index is FDA-approved and supported by substantial scientific validation.
"there's actually a um one of the markers we use is actually called Sleep Quality Index. It's FDA-approved, tons of of of evidence behind it." (said at 3:26:24)
The speaker claims that the "Sleep Quality Index" (often referring to the Pittsburgh Sleep Quality Index or single-item Sleep Quality Scale) is an "FDA-approved" metric. However, the U.S. Food and Drug Administration (FDA) regulates medical devices, biological products, and pharmaceutical drugs; it does not standardly clear or approve questionnaires, self-report clinical rating scales, or psychometric indexes. While sleep measurement questionnaires (such as the Pittsburgh Sleep Quality Index or the single-item Sleep Quality Scale) possess extensive scientific validation and are widely utilized in clinical research and FDA-regulated clinical trials to assess drug efficacy, the metric itself is not an FDA-approved entity. Because the claim asserts FDA regulatory approval for a questionnaire/metric, it is contradicted by how FDA regulatory scope functions.
Adverse effects from indoor carbon dioxide levels primarily occur at concentrations of 2,000 to 3,000 parts per million, whereas levels around 1,200 to 1,300 ppm are common and generally not severely problematic.
"You will see typically um 1,200, 1,300 in people like really consistently. That's not that bad. Most of the problems happen at like 2,000, 2,500, 3,000." (said at 3:35:15)
Controlled laboratory exposure studies and prospective observational research demonstrate that adverse effects on human cognitive function and decision-making performance begin at indoor carbon dioxide (CO2) concentrations of 1,000 to 1,500 ppm, rather than primarily starting at 2,000 to 3,000 ppm. A double-blind controlled exposure study found moderate, statistically significant decrements across six of nine decision-making domains at 1,000 ppm compared to 600 ppm (Satish et al., 2012). Similarly, a flight simulator study in commercial pilots showed statistically significant declines in flight maneuver performance at 1,500 ppm compared to 700 ppm (Allen et al., 2019). Multi-country observational research in office workers also demonstrates progressive increases in response times and reductions in cognitive accuracy for incremental increases in indoor CO2 within typical workplace ranges (Allen et al., 2021). While concentrations of 2,000 to 3,000 ppm cause larger performance decrements, asserting that levels around 1,200 to 1,300 ppm are generally not problematic and that most problems only occur at 2,000 to 3,000 ppm is contradicted by published research.
- contradicts: Is CO2 an indoor pollutant? Direct effects of low-to-moderate CO2 concentrations on human … (Environmental health perspectives 2012) · cited 1021x in the literature
"Relative to 600 ppm, at 1,000 ppm CO2, moderate and statistically significant decrements occurred in six of nine scales of decision-making performance." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Airplane pilot flight performance on 21 maneuvers in a flight simulator under varying carb… (Journal of exposure science & environmental epidemiology 2019) · cited 97x in the literature
"Compared to segments at a CO 2 concentration of 2500 ppm, the odds of passing a maneuver as rated by the Examiner in the simulator were 1.52 (95% CI: 1.02-2.25) times higher when pilots were exposed to 1500 ppm and 1.69 (95% CI: 1.11-2.55) times higher when exposed to 700 ppm, controlling for maneuver difficulty, Examiner and order of maneuvers." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Associations between Acute Exposures to PM 2.5 and Carbon Dioxide Indoors and Cognitive Fu… (Environmental research letters : ERL [Web site] 2021) · cited 56x in the literature
"For CO 2, an IQR increase (IQR=315ppm) was associated with a 0.85% (95% CI: 0.32, 1.39) increase in Stroop response time, a 7.88% (95% CI: 2.08, 13.86) increase in Stroop interference time, a 1.32% (95% CI: -2.3, -0.38) decrease in Stroop throughput, and a 1.13% (95% CI: 0.18, 2.11) increase in ADD response time." (abstract, results, passage verified)
pubmedfull study (doi)
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.